According to Spero Therapeutics's latest financial reports the company's current earnings (TTM) are $25.4 M. In 2022 the company made an earning of -$43.81 M an increase over its 2021 earnings that were of -$87.87 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $25.4 M | -157.99% |
2022 | -$43.81 M | -50.14% |
2021 | -$87.87 M | 11.06% |
2020 | -$79.12 M | 25.15% |
2019 | -$63.22 M | 47.68% |
2018 | -$42.81 M | 5.61% |
2017 | -$40.54 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
IBM IBM | $8.69 B | 34,107.21% | ๐บ๐ธ USA |
Thomson Reuters
TRI | $1.98 B | 7,725.54% | ๐จ๐ฆ Canada |
Franklin Covey FC | $23.71 M | -6.64% | ๐บ๐ธ USA |